Cash and cash equivalents (USD, thousands)

Short-term investment securities (USD, thousands)

TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Prepaid income taxes (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Assets held for sale (USD, thousands)

TOTAL CURRENT ASSETS (USD, thousands)

PROPERTY, PLANT AND EQUIPMENT, net (USD, thousands)

OPERATING LEASE RIGHT-OF-USE ASSETS (USD, thousands)

GOODWILL (USD, thousands)

INTANGIBLE ASSETS, net (USD, thousands)

DEFERRED INCOME TAXES - Assets (USD, thousands)

OTHER ASSETS - Assets (USD, thousands)

TOTAL ASSETS (USD, thousands)

Accounts payable (USD, thousands)

Accrued liabilities (USD, thousands)

Current portion of long-term debt (USD, thousands)

Income tax payable (USD, thousands)

Liabilities held for sale (USD, thousands)

TOTAL CURRENT LIABILITIES (USD, thousands)

LONG-TERM DEBT (USD, thousands)

OTHER LONG-TERM LIABILITIES (USD, thousands)

DEFERRED INCOME TAXES - Liabilities (USD, thousands)

INCOME TAX LIABILITY (USD, thousands)

Common stock, $ 0.10 par value (USD, thousands)

Additional paid-in capital (USD, thousands)

Treasury stock, at cost (USD, thousands)

Retained earnings (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

TOTAL STOCKHOLDERS' EQUITY (USD, thousands)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (USD, thousands)

7d8efcaa4741b70d74df97a70e02a38f2be082c3ee193b15395a5dc0975bb523

Total Revenues (USD, thousands)

Cost of Goods Sold (USD, thousands)

Gross Profit (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Research and Development Expenses (USD, thousands)

Restructuring, Strategic Transaction and Integration Expenses (USD, thousands)

Change in Fair Value of Contingent Earn-Out (USD, thousands)

Total Operating Expenses (USD, thousands)

Income (Loss) from Operations (USD, thousands)

Interest Expense, Net (USD, thousands)

Other Expense, Net (USD, thousands)

Loss Before Income Taxes (USD, thousands)

(Provision) Benefit for Income Taxes (USD, thousands)

Net Loss (USD, thousands)

Net Loss per Share Basic (USD)

Net Loss per Share Diluted (USD)

Weighted Average Number of Shares Basic (Thousands)

Weighted Average Number of Shares Diluted (Thousands)

ee5e7d2aa79e0d79dea437c9919a75eb4e012ffba6b443ce06dff0ddbb08c3fd

80bf0ccdd9e95bf59cf725d29fb25a086ae8068f61683061c15241ad3cee870f

United States

Europe, the Middle East, and Africa

Asia-Pacific

Other Foreign

- Canada

- Latin America (LATAM)

Total Revenue

5e9e9d5653ad001eadcc2c926da4d2bc9af7ff8f3f4f08e00e3803b1cd8a2865

Consumables

- GAAP Revenue

- Constant Currency Revenue

Infusion Systems

Vital Care

b895e11d6a8c4436db383fbfccb98e542afb3b62c47b79261370e87e1df7e654

ICU MEDICAL INC/DE (ICUI)

Financials